Original Article

Changes in Nonosteoporotic Bone Density and Subsequent Fractures in Women

Authors: Alfred K. Pfister, MD, Christine A. Welch, MS, Molly John, MD, Mary K. Emmett, PhD

Abstract

Objectives: Osteopenia is considerably more common than osteoporosis and accounts for most of the fracture burden in women older than 50 years. It is uncertain when to initiate treatment in osteopenia. We sought to determine in women with osteopenia what effect transitioning to lower categories had on subsequent fracturing.

Methods: We surveyed 1150 women from office-based practices who had initial normal or osteopenic bone mineral densities (BMDs) and who were retested after 5.75 years. We classified categories related to baseline T scores as follows: normal (>−1.0), mild osteopenia (−1.0 to −1.49), moderate osteopenia (−1.5 to −1.99), and severe osteopenia (−2.0 to −2.49). We determined during a 9.6-year follow-up period the fracture occurrence in those who maintained their initial category status or transitioned into lower categories.

Results: Transitioning to lower categories was not significantly different among baseline osteopenic categories but significantly more than normal baseline BMDs. Total fractures, individuals fracturing, and major fractures were significantly more, with baseline T scores of ≤−1.5 (<0.001). Although only 10.2% transitioned to osteoporosis, 90.5% of these transitions occurred with baseline T scores ≤−1.5 and accounted for significantly more fractures than baseline T scores of >−1.5.

Conclusions: Most subsequent fractures and transitions to osteoporosis occurred with baseline T scores ≤−1.5. Clinical risk factors need to be used to determine at what T score threshold treatment would be cost effective.

 

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Stone KL, Seeley DG, Lui LY, et al. BMD at multiple sites and risk of fracture of multiple types: long-term results from the Study of Osteoporotic Fractures. J Bone Miner Res 2003;18:1947-1954.
 
2. Nevitt MC, Cummings ST, Stone KL, et al. Risk factors for a first-incident radiographic vertebral fracture in women 9 or = 65 years of age: the study of osteoporotic fractures. J Bone Miner Res 2005;20:131-140.
 
3. Barrett-Connor E, Siris ES, Wehren LE, et al. Osteoporosis and fracture risk in women of different ethnic groups. J Bone Miner Res 2005;20:185-194.
 
4. Cranney A, Jamal SA, Tsang JF, et al. Low bone mineral density and fracture burden in postmenopausal women. CMAJ 2007;177:575-580.
 
5. Langsetmo L, Goltzman D, Kovacs CS, et al. Repeat low-trauma fractures occur frequently among men and women who have osteopenic BMD. J Bone Miner Res 2009;24:1515-1522.
 
6. Looker AC, Melton LJ 3rd, Harris TB, et al. Prevalence and trends in low femur bone density among older US adults: NHANES 2005Y2006 compared with NHANES III. J Bone Miner Res 2010;25:64-71.
 
7. America’s Bone Health: The State of Osteoporosis and Low Bone Mass in Our Nation. Washington, DC: National Osteoporosis Foundation, 2002.
 
8. Malabanan AO, Rosen HN, Vokes TJ, et al. Indications of DXA in women younger than 65 yr and men younger than 70 yr: the 2013 Official Positions. J Clin Densitom 2013;16:467-471.
 
9. National Osteoporosis Foundation. 2013 clinician’s guide to prevention and treatment of osteoporosis. http://nof.org/files/nof/public/content/file/917/upload/481.pdf. Accessed November 24, 2015.
 
10. US Preventive Services Task Force. Screening for osteoporosis: U.S. preventive services task force recommendation statement. Ann Intern Med 2011;154:356-364.
 
11. Cauley JA, Robbins J, Chen Z, et al. Effects of estrogen plus progestin on risk of fracture and bone mineral density: the Women’s Health Initiative randomized trial. JAMA 2003;290:1729-1738.
 
12. Kanis JA, Johnell O, Black DM, et al. Effect of raloxifene on the risk of new vertebral fracture in postmenopausal women with osteopenia or osteoporosis: a reanalysis of the Multiple Outcomes of Raloxifene Evaluation trial. Bone 2003;33:293-300.
 
13. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA 1998;280:2077-2082.
 
14. Quandt SA, Thompson DE, Schneider DL, et al. Effect of alendronate on vertebral fracture risk in women with bone mineral density T scores of j1.6 to j2.5 at the femoral neck: the Fracture Intervention Trial. Mayo Clin Proc 2005;80:343-349.
 
15. Siris ES, Simon JA, Barton IP, et al. Effects of risedronate on fracture risk in postmenopausal women with osteopenia. Osteoporos Int 2008;19:681-686.
 
16. Phillipov G, Seaborn CJ, Phillips PJ. Reproducibility of DXA: potential impact on serial measurements and misclassification of osteoporosis. Osteoporos Int 2001;12:49-54.
 
17. Gourlay ML, Fine JP, Preisser JS, et al. Bone-density testing interval and transition to osteoporosis in older women. N Engl J Med 2012;366:225-233.
 
18. Hillier TA, Stone KL, Bauer DC, et al. Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. Arch Intern Med 2007;167:155-160.
 
19. Berry SD, Samelson EJ, Pencina MJ, et al. Repeat bone mineral density screening and prediction of hip and major osteoporotic fracture. JAMA 2013;310:1256-1262.
 
20. Berger C, Langsetmo L, Joseph L, et al. Association between change in BMD and fragility fracture in women and men. J Bone Miner Res 2009;24:361-370.
 
21. Shagina NB, Tolstykh EI, Degteva MO, et al. Cortical bone resorption rate in elderly persons: estimates from long-term in vivo measurements of (90)Sr in the skeleton. Arch Gerontol Geriatr 2012;54:e411-e418.
 
22. Kijowski R, Tuite M, Kruger D, et al. Evaluation of trabecular microarchitecture in nonosteoporotic postmenopausal women with and without fracture. J Bone Miner Res 2012;27:1494-1500.
 
23. Ladinsky GA, Vasilic B, Popescu AM, et al. Trabecular structure quantified with the MRI-based virtual bone biopsy in postmenopausal women contributes to vertebral deformity burden independent of areal vertebral BMD. J Bone Miner Res 2008;23:64-74.
 
24. Bala Y, Zebaze R, Ghasem-Zadeh A, et al. Cortical porosity identifies women with osteopenia at increased risk for forearm fractures. J Bone Miner Res 2014;29:1356-1362.
 
25. Stein EM, Liu XS, Nickolas TL, et al. Abnormal microarchitecture and reduced stiffness at the radius and tibia in postmenopausal women with fractures. J Bone Miner Res 2010;25:2572-2581.
 
26. Recommendations for the prevention and treatment of glucocorticoidinduced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001;44:1496-1503.
 
27. Netelenbos JC, Lems WF, Geusens PP, et al. Spine radiographs to improve the identification of women at high risk for fractures. Osteoporos Int 2009;20:1347-1352.
 
28. Lindsay R, Silverman SL, Cooper C, et al. Risk of new vertebral fracture in the year following a fracture. JAMA 2001;285:320-323.
 
29. Schousboe JT, Nyman JA, Kane RL, et al. Cost-effectiveness of alendronate therapy for osteopenic postmenopausal women. Ann Intern Med 2005;142:734-741.
 
30. Moriwaki K, Komaba H, Noto S, et al. Cost-effectiveness of alendronate for the treatment of osteopenic postmenopausal women in Japan. J Bone Miner Res 2013;28:395-403.
 
31. Kanis JA, Oden A, Johansson H, et al. FRAX and its applications to clinical practice. Bone 2009;44:734-734.
 
32. Baim S, Wilson CR, Lewiecki EM, et al. Precision assessment and radiation safety for dual-energy X-ray absorptiometry: position paper of the International Society for Clinical Densitometry. J Clin Densitom 2005;8:371-378.
 
33. Faulkner KG, von Stetten E, Miller P. Discordance in patient classification using T-scores. J Clin Densitom 1999;2:343-350.
 
34. Raisz LG. Clinical practice. Screening for osteoporosis. N Engl J Med 2005;353:164-171.
 
35. Schneyer CR, Lopez H, Concannon M, et al. Assessing population risk for postmenopausal osteoporosis: a new strategy using data from the Behavioral Risk Factor Surveillance System (BRFSS). J Bone Miner Res 2008;23:151-158.